





Drug resistant infectious diseases are a part of emerging infectious diseases worldwide. They have steadily increased in incidence over time and are still increasing presently all over the world. This is a huge public health problem and therefore reduction in these diseases is of great public health relevance. A literature review was done to examine the extent of drug – resistant infectious disease and the potential contribution to this problem by the rampant use of antibiotics, improper use of prescribed antibiotics and the healthcare system in Nigeria. Rampant use of antibiotics is a health issue in Nigeria because pharmacists and chemists act as physicians and prescribe unnecessary antibiotics for the requesting public. Education about the consequences of inappropriate use of antibiotics seems to have gone without notice. The use of antibiotics not recommended by physicians is astounding. Even worse is the over the counter availability of a large amount of the existing antibiotics in the country.

Poor drug quality is also a major contributing factor. The National Agency for Food and Drug Administration and Control (NAFDAC) is a Nigerian (​http:​/​​/​en.wikipedia.org​/​wiki​/​Nigeria" \o "Nigeria​) government agency (​http:​/​​/​en.wikipedia.org​/​wiki​/​Government_agency" \o "Government agency​) under the Federal Ministry of Health (​http:​/​​/​en.wikipedia.org​/​wiki​/​Federal_Ministry_of_Health_%28Nigeria%29" \o "Federal Ministry of Health (Nigeria)​) that is responsible for regulating and controlling the manufacture, importation, exportation, advertisement, distribution, sale and use of food (​http:​/​​/​en.wikipedia.org​/​wiki​/​Food" \o "Food​), drugs (​http:​/​​/​en.wikipedia.org​/​wiki​/​Drugs" \o "Drugs​), cosmetics (​http:​/​​/​en.wikipedia.org​/​wiki​/​Cosmetics" \o "Cosmetics​), medical devices (​http:​/​​/​en.wikipedia.org​/​wiki​/​Medical_devices" \o "Medical devices​), chemicals (​http:​/​​/​en.wikipedia.org​/​wiki​/​Chemicals" \o "Chemicals​) and packaged water (​http:​/​​/​en.wikipedia.org​/​wiki​/​Water" \o "Water​). Counterfeit medications are dangerous and should not be sold in any country. Ineffective enforcement of existing laws by NAFDAC allows for several unregistered pharmacies all over the country.
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1.0 	Introduction
Drug Resistant infectious diseases are a part of emerging infectious diseases worldwide. They have steadily increased in incidence over time and are still increasing presently all over the world. This is a huge public health problem and therefore reduction in these diseases is of great public health relevance. A literature review was done to examine the extent of drug – resistant infectious disease and the potential contribution to this problem by the rampant use of antibiotics, improper use of prescribed antibiotics and the healthcare system in Nigeria. Rampant use of antibiotics is a health issue in Nigeria because pharmacists and chemists act as physicians and prescribe unnecessary antibiotics for the requesting public. Education about the consequences of inappropriate use of antibiotics seems to have gone without notice. The use of antibiotics not recommended by physicians is astounding. Even worse is the over the counter availability of a large amount of the existing antibiotics in the country.

Drug quality is also a major contributing factor. The National Agency for Food and Drug Administration and Control (NAFDAC) is a Nigerian (​http:​/​​/​en.wikipedia.org​/​wiki​/​Nigeria" \o "Nigeria​) government agency (​http:​/​​/​en.wikipedia.org​/​wiki​/​Government_agency" \o "Government agency​) under the Federal Ministry of Health (​http:​/​​/​en.wikipedia.org​/​wiki​/​Federal_Ministry_of_Health_%28Nigeria%29" \o "Federal Ministry of Health (Nigeria)​) that is responsible for regulating and controlling the manufacture, importation, exportation, advertisement, distribution, sale and use of food (​http:​/​​/​en.wikipedia.org​/​wiki​/​Food" \o "Food​), drugs (​http:​/​​/​en.wikipedia.org​/​wiki​/​Drugs" \o "Drugs​), cosmetics (​http:​/​​/​en.wikipedia.org​/​wiki​/​Cosmetics" \o "Cosmetics​), 
medical devices (​http:​/​​/​en.wikipedia.org​/​wiki​/​Medical_devices" \o "Medical devices​), chemicals (​http:​/​​/​en.wikipedia.org​/​wiki​/​Chemicals" \o "Chemicals​) and packaged water (​http:​/​​/​en.wikipedia.org​/​wiki​/​Water" \o "Water​). Counterfeit medications are dangerous and should not be sold in any country. Ineffective enforcement of existing laws by NAFDAC allows for several unregistered pharmacies all over the country.
1.1	Antimicrobial Resistance
Ever since the discovery of Penicillin and its successful use as an antibiotic, there have been a wide range of antibiotics produced that have helped greatly in the reduction of infectious diseases. The effectiveness of antibiotics cannot be disputed. Over the years however, micro-organisms have found ways to avoid being killed by adapting and mutating. These microbes have become resistant to previously effective medication, resulting in increased costs to treat an otherwise simple infection. This rise of antimicrobial resistance in many communities world-wide has caused an emerging infectious disease of great threat to public health.





Below is a figure from the Centers for Disease Control and Prevention (CDC) showing the increasing trends in antimicrobial resistance of a few micro-organisms. In the examples given, methicillin resistant Staphylococcus aureus (MRSA) saw a 50% increase in incidence by the year 2000 with vancomycin resistant Enterobacteriacea (VRE) and Fluoroquinolone resistant Pseudomonas aeruginosa (FRQP) following the same pattern. 


Figure 1: Pattern of Antibiotic-Resistant Infections Over Time

Streptococcus pneumoniae is a commonly implicated agent in invasive disease. For infections of S. pneumoniae resistant to b-lactam, macrolides are an alternative treatment. However, resistance to macrolides has increased worldwide as well. In Colombia, the frequency of resistance to erythromycin was determined for S. pneumoniae over a 15-year surveillance period, and the resistant isolates were characterized phenotypically and genotypically. Demographic data of the patients, antimicrobial susceptibility and serotypes were analyzed for 3,241 S. pneumoniae isolates recovered between 1994 and 2008. Of the 3,241 isolates, 136 were resistant to erythromycin. In the 12-year period between 1994-1996 and 2006-2008, resistance in each 2-year sampling had increased from 2.4% to 6.9% in children under 6 years and from 3.3% to 5.7% in adults [2]. A study done by Grunt et al in Slovakia compared results of antibiotic resistance of strains belonging to 9 species of so-called Problem bacteria recorded by 10 District Public Health Laboratories during 6 months of 1977 (altogether 32641 strains). In classical antibiotics, a typical steady-state situation was established in that period. Beta-lactam antibiotics in general deteriorated in gram negatives, with certain improvements in special cases. In "specific pathogens", i.e. enteropathogenic strains of E. coli and in strains of P. aeruginosa, resistance to antibiotics generally increased. On the other hand, in S. aureus strains a better susceptibility to almost all antibiotics could be recorded [3].

Methicillin-resistant Staphylococcus aureus (MRSA) is probably one of the most common drug resistant infections at this time. Controlling its spread over the years has been very difficult: it has spread from hospital settings into the community. MRSA is defined as community acquired if the MRSA-positive specimen was obtained outside hospital settings or within 2 days of hospital admission, and if it was from a person who had not been hospitalized within 2 years before the date of MRSA isolation. Salmenlinna et al estimated the proportion of community-acquired MRSA and analyzed previous hospitalizations for all MRSA-positive persons in Finland from1997 to 1999 by using data from the National Hospital Discharge Register. Of 526 MRSA-positive persons, 21% had community-acquired MRSA. Three MRSA strains identified by phage typing, pulsed-field gel electrophoresis, and ribotyping were associated with community acquisition. None of the strains were multiresistant, and all showed a mec hypervariable region hybridization pattern A (HVR type A). None of the epidemic multiresistant hospital strains were prevalent in non-hospitalized persons. Their population-based data suggest that community-acquired MRSA may also arise de novo, through horizontal acquisition of the mecA gene [4].

There is increasing concern about the impact on public health of methicillin-resistant Staphylococcus aureus (MRSA) associated with animal food products. MRSA remains a serious problem because of the high incidence and multidrug resistance of the strains, even for strains isolated from foods, food environments and food handlers. Paludi et al evaluated the susceptibility of S. aureus strains isolated from food, food handlers and food-processing environments to 14 antibiotics currently used in veterinary and human therapy and assessed the presence of the mecA gene in Italy. A total of 1007 samples were collected from food, food handlers, and environments and were analyzed for the presence of S. aureus. S. aureus was present in 165 of the 1007 samples. A total of 157 isolates were methicillin-susceptible S. aureus (MSSA) and 8 isolates were MRSA. In particular, out of 8 MRSA strains detected, 4 strains harboured the mecA gene. All MRSA strains were resistant to at least one of the tested antibiotics and 6 strains demonstrated multi-resistance. Considering the high level of resistances in S. aureus and the isolation of MRSA strains, the surveillance of antimicrobial resistance and the spreading of this pathogen is of crucial importance in the food production chain [5]

A repeated cross-sectional study was conducted by Raida et al to determine the patterns of antimicrobial resistance in 1,286 Escherichia coli strains isolated from human sewage, wildlife, domestic animals, farm environments, and surface water in the Red Cedar watershed in Michigan. Isolation and identification of E. coli were done by using enrichment media, selective media, and biochemical tests. Antimicrobial susceptibility testing by the disk diffusion method was conducted for Neomycin, Gentamicin, Streptomycin, Chloramphenicol, Ofloxacin, Trimethoprim-Sulfamethoxazole, Tetracycline, Ampicillin, Nalidixic acid, Nitrofurantoin, Cephalothin, and Sulfisoxazole. Resistance to at least one antimicrobial agent was demonstrated in isolates from livestock, companion animals, human sewage, wildlife, and surface water [6].
Enterococci have the potential for resistance to virtually all clinically useful antibiotics. Their emergence as important nosocomial pathogens has coincided with increased expression of antimicrobial resistance by members of the genus. Their mechanisms of antibiotic resistance may be intrinsic to the species or acquired through mutation of intrinsic genes or horizontal exchange of genetic material encoding resistance determinants [7].
1.1.1	Mechanisms of Antimicrobial Resistance
The four main mechanisms by which microorganisms exhibit resistance to antimicrobials are [8]:
1)	Drug inactivation or modification: for example, enzymatic deactivation of Penicillin G in some penicillin-resistant bacteria through the production of lactamases.
2)	Alteration of target site: for example, alteration of PBP- the binding target site of Penicillins - in MRSA and other penicillin-resistant bacteria.
3)	Alteration of metabolic pathway: for example, some sulfonamide-resistant bacteria do not require para-aminobenzoic acid (PABA), an important precursor for the synthesis of folic acid and nucleic acids in bacteria inhibited by sulfonamides. Instead, like mammalian cells, they turn to utilizing preformed folic acid.
4)	Reduced drug accumulation: by decreasing drug permeability and/or increasing active efflux (pumping out) of the drugs across the cell surface.
1.1.2	Inappropriate Use of Antibiotics
In a study by Kardas-Sloma, they aimed to assess the impact of antibiotic prescription patterns on the selection of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) within hospitals, in a context of competition with other circulating staphylococcal strains, including methicillin-sensitive (MSSA) and hospital-associated methicillin-resistant (HA-MRSA) strains. They developed a computerized agent-based model of S. aureus transmission in a hospital ward in which CA-MRSA, MSSA, and HA-MRSA strains may co-circulate. They investigated a wide range of antibiotic prescription patterns in both intensive care units (ICUs) and general wards, and studied how differences in antibiotic exposure may explain observed variations in the success of CA-MRSA invasion in the hospitals of several European countries and of the United States. Model predictions underlined the influence of antibiotic prescription patterns on CA-MRSA spread in hospitals, especially in the intensive care unit (ICU), where the endemic prevalence of CA-MRSA carriage can range from 3% to 20%, depending on the simulated prescription pattern. Large antibiotic exposure with drugs effective against MSSA but not MRSA was found to promote invasion by CA-MRSA. They also found that, should CA-MRSA acquire fluoroquinolone resistance, a major increase in CA-MRSA prevalence could ensue in hospitals worldwide. 

Controlling the spread of highly community-prevalent CA-MRSA within hospitals is a challenge and this study demonstrates that antibiotic exposure strategies could participate in this control  [9].

There is little data regarding the use of antibiotics in Nigeria but in a study done by Tamuno et al, self-administered, pretested, semi structured questionnaires were used to collect data from 354 students pursuing different courses of study in Bayero University Kano, North western Nigeria and at different stages, using multistage sampling. They explored the fact that antibiotic access is made easier in developing countries by availability and poor regulatory and weak health systems. Fever was the most common reason for the use (48.4%). Metronidazole was the most common antibiotic involved (23.2%) while chloramphenicol was the least used (1.1%). While 38.6% of the respondents used antibiotics for self-medication because they had used the same drug for similar conditions, patent pharmacies were the most common source (64.4%) of antibiotics. 90% of the respondents used antibiotics for less than five days [10]. Tamuno et al also evaluated the prescribing pattern of clinicians in the general outpatient unit of the Aminu Kano Teaching Hospital, Kano and found that antibiotics prescribed was only second to analgesic prescription surpassing antimalarials and antihypertensives. They concluded that overuse of antibiotics still remains a problem in the healthcare facilities in Nigeria [11]. Obaseiki-Ebor et al assessed both patterns of antibiotic prescribing and self-medication by carrying out a survey on patients from Government and private hospitals (500 each) and on 1000 apparently healthy adults in Benin City, Nigeria. Ampicillin and tetracycline were the antibiotics commonly used for self-medication; the commonest reasons given for the self-medication were the treatment of sexually transmitted diseases, cough, stomach upsets and diarrhea. 
Ampicillin was the commonest prescribed antibiotic; the commonest indications for prescription were soft-tissue, sexually transmitted, upper respiratory and gastro-intestinal infections. According to an assessment by four clinicians from a panel of eight in Government and private practice, 52% of the total prescriptions were judged to be appropriate whereas 30% were judged to be inappropriate by a majority of the physicians [12].

Other studies were done on the prescribing patterns of doctors in Nigerian health care facilities. Adebayo et al examined three Nigerian Army hospitals using some WHO criteria, and the knowledge and attitude underlying doctors' prescribing practices in these hospitals. Data collected from 660 case notes showed that average number of drugs per encounter was 2.8 while 49.3% of drugs were prescribed in the generic form. An average of 28.1% of patients encountered antibiotics. From the knowledge, attitude and practice survey, it is evident that 90.5% of 74 prescribers were aware of the existence of national essential drugs list but 58.1% of them did not use it as basis of prescriptions. The pattern noted was characterized by high number of drugs per prescription, high rate of antibiotic usage and unscientific prescription by doctors [13]. Akande et al chose a secondary health care facility in Ilorin. They examined 303 randomly selected prescriptions issued to patients attending out-patients' clinics in the facility over a period of three months and found that at least 4 drugs were prescribed in 61.6% of the prescriptions. Generic prescribing was generally low (generic names are generally cheaper than brand names). Out of a total of 1219 drugs prescribed, 511 (41.9%) were prescribed in generic names. Analgesics, antimalarials, antibiotics and antihypertensives accounted for 19.7%, 10.2%, 13.0% and 4.9% of the drugs prescribed respectively [14]. Nwolisa et al studied medications prescribed to children under five who attended an outpatient clinic. After 4 months, a total of 2471 medications were prescribed for 790 patients who met the criteria for inclusion in the study (children with no prescriptions were excluded). Antimalarials, analgesics, antibiotics, vitamin C, antihistamines and multivitamin preparations were the commonest drugs prescribed. The prescription rate per patient was 3.13. While three different antimalarials were prescribed a total of twelve different antibiotics were. This study documented significant flaws in the prescribing practices of these doctors, particularly the low rate of prescription in generic names, high rate of antibiotics prescription, inappropriate prescription of multivitamin preparations and vitamin C and a relatively high rate of poly pharmacy [15]. 
1.1.3	Non-compliance to Drug Therapy
Non-compliance is a major contributing factor, it has led to the emergence of multi-drug resistant tuberculosis, and poor treatment outcome. To determine the frequency, types and severity of medications use-related problems among medical outpatients, Yusuff et al conducted a cross-sectional medication use review in a tertiary care setting in southwestern Nigeria. Of the 400 randomly selected patients, 324 (81.0%) consented and were interviewed. They found that the most frequent problems were non-adherence (43.8%), problems associated with self- medication (39.3%) and adverse drug reactions (15.6%). Unauthorized drug holidays (46.5%) and stoppage of prescribed prescription-only medications for local herbs (29.3%) were the major consequences of non-adherence. Potentially harmful drug-disease interactions were the most frequent medication use-related problems arising from self-medication (40.4%) [16].

Ifebunandu et al aimed to determine the prevalence, trend, timing and predictors of defaulting from tuberculosis treatment in a Nigerian tertiary hospital. Five years of data was reviewed and of 671 tuberculosis patients, 192 (28.6%) defaulted. Of these, 126 (66%) were ≥30 years old, and 115 (60%) had pulmonary tuberculosis. The annual proportion of defaulters dropped from 34.8% to 20.6%, but the decreasing trend was not statistically significant (P=0.132 for trend). Of the defaulters, 148 (77.1%) defaulted during their intensive phase of treatment. The median default time was 7 weeks and independent predictors of treatment default were older age, rural residence,  and HIV seropositivity [17].
1.1.4	Poor Drug Quality
In Nigeria there is constant importation of counterfeit goods and drugs are not any different. The use of low quality drugs to combat infectious diseases will definitely be ineffective with treatment failure and subsequently possible drug resistance. There are many unlicensed pharmacies in different corners in Nigeria. NAFDAC is responsible for inspecting and investigating all of these drug products. Public awareness on drug matters has been described as well below average by the Pharmaceutical Society of Nigeria [18]. 

Shakoor et al assessed the incidence of substandard drugs. They collected 96 samples of Chloroquine and selected antibacterials from Nigeria and Thailand in a controlled and methodical manner and analysed them using appropriately validated methods based on high-performance liquid chromatography capable of detecting drug-related impurities and quantifying active drug(s). The results indicate that 36.5% of the samples were substandard with respect to pharmacopoeial limits. Decomposition was the cause of poor quality in a number of the samples but overall, poor manufacturing appeared to be prevalent [18].

It is a common scene in Nigeria to see petty traders who sell kolanuts, cigarettes and oranges among other items in market kiosks, motor parks and roadside hawking drugs that range from over the counter items to antibiotics (popularly called capsules). The medicines are usually left under the sun in such conditions that could facilitate the deterioration of the active ingredients. Considering the knowledge base of these vendors whose minimum requirement to obtain a license is the first school-leaving and who are only authorized to sell over the counter medications, they are not in a good position to differentiate between fake and genuine products. In a study done by oral interviews and questionnaires, Erhun et al found that reasons adduced for availability of counterfeit drugs in Nigeria included ineffective enforcement of existing laws, non-professionals in drug business, loose control systems, high cost of drugs, greed of regulatory officials, ignorance of the public and level of corruption in the country [19].







1.2	Antimicrobial Resistance and public health 
One of the major public health concerns of antimicrobial resistance is the mode and rapidity of its spread. Efforts to prevent and control those diseases are among the most practical and achievable ways of alleviating poverty and furthering social and economic development. If we fail, increased drug resistance and the emergence of new bacteria and viruses threaten to make the control of infectious diseases both scientifically and economically unlikely in the future [20]. Most deaths from infectious diseases - almost 90% - are caused by only a handful of diseases. No more than six deadly infectious diseases - pneumonia, tuberculosis, diarrheal diseases, malaria, measles and more recently HIV/AIDS - account for half of all premature deaths, killing mostly children and young adults [20]. 

Figure 2: Leading Infectious Killer Worldwide, 1998
Above is a graph of the leading infectious diseases causing mortality worldwide according to the World Health Organization (WHO) from 1998. In 2010, these statistics have not changed much.


About half of the world’s under-five deaths in 2012 still occurred in only five countries: India, Nigeria, Democratic Republic of the Congo, Pakistan and China. India (22%) and Nigeria (13%) together account for more than a third of under-five deaths worldwide. 58% of deaths in children under age five are caused by infectious diseases [21]. This is happening at a time when the arsenal of drugs available to treat infectious diseases is being progressively depleted due to increasing resistance of microbes to antimicrobial drugs [20].






The table above is from the WHO Global Health Observatory Data Repository.  According to WHO, in 2012 the leading causes of death in children under-five years old in Nigeria are malaria, acute lower respiratory infections, diarrheal diseases, HIV/AIDS and measles [21].

Akinwusi et al conducted a retrospective study of communicable disease (CD)-related sudden death (SD) in adult patients aged 18 years and older that occurred from January 2003 to December 2011 at the Ladoke Akintola University of Technology Teaching Hospital (Osogbo, Osun State, Nigeria) - a tertiary health facility in southwest Nigeria. There were 17 (39.6%) CD-related SDs out of the 48 cases of SD studied. Typhoid sepsis was responsible for SD in 47.1% of patients, pulmonary tuberculosis in 17.7% of patients, and lobar pneumonia in 17.7% of patients. The most affected age group was the 20-29-year-old group (41.2%) [22].





Figure 3: Disability Adjusted Life Years Due to Infectious Diseases, 1998

The graph above is from the WHO report on infectious diseases from 1998 highlighting the burden of infectious diseases worldwide.

1.2.1	Acute lower respiratory infections
Acute respiratory infections (ARIs) are responsible for many deaths. In a 9-month surveillance of the microbial agents causing acute lower respiratory infections (ALRI) in hospitalized preschool Nigerian children, 24 bacterial isolates were made from 22 (33%) out of 66 blood cultures, including seven (70%) of the 10 cultures from subjects with pleural effusion. Of the 24 positive isolates, Staphylococcus aureus accounted for 14 (58%), Klebsiella pneumoniae for four (17%), Streptococcus pneumoniae and Staphylococcus albus for two (8%) each, and Haemophilus influenzae for only one case [23]. A retrospective study of 438 patients seen in 12 months (2000) with microbial pathogens from urinary and respiratory tracts was undertaken in Savannah Northern Nigeria by Habib et al. Pneumococci were non-susceptible to Penicillin (93%), Cotrimoxazole (92%), Tetracycline (84%), Ampicillin (53%), Chloramphenicol (21%) and Cefazolin (8%). [24]. 

Some studies have shown drug susceptibility and resistance to the same group of drugs. An open clinical study to assess the efficacy and tolerance of Roxithromycin (a macrolide) 150 mg twice daily was carried out amongst Nigerian patients with upper and lower respiratory tract infections at Plateau Hospital Jos. Twenty-two patients aged between 13 and 86 years comprising of twelve women, seven men and three children completed the study. 18 (81.8%) had bronchopulmonary infections, 3 (13.6%) had tonsillitis and 1 (4.6%) had otitis media. Pathogens isolated included Streptococcus pneumonia (22.7%), Streptococcus pyogenes (13.6%), Bramhella catarrhalis (9.1%), Haemophilus influenzae (9.1%), Staphylococcus aureus (4.6%), Klebsiella species (4.6%), Pseudomonas aeruginosa (4.6%). There was 88.2% bacteriological cure and patients responded fast, with no major adverse reactions. Roxithromycin (a macrolide) was therefore concluded to be an effective well tolerated drug for treatment of respiratory tract infections in Nigerians [25]. In a study of 305 sputum samples collected from patients with clinically diagnosed pneumonia in Abakaliki. Streptococcus pneumoniae was isolated in all cases with susceptibility studies showing the highest resistance- 182 for Penicillin, 156 for Septrin, 120 for Erythromycin, 118 for Clavulanic/Amoxicillin, 114 for Cefotaxime, 100 for Clarithromycin, 94 for Ciprofloxacin, 75 for Gentamycin, 70 for Cefuroxime and 69 for Ceftriaxone [26], Erythromycin and Clarithromycin are both macrolides.
 
In developing an antibiogram of bacterial isolates, 204 sputum samples from cases of lower respiratory tract infections were screened. Moraxella catarrhalis, S. aureus, S. pneumoniae and H. influenzae constituting 20.9%, 37%, 30% and 21% were isolated in that order. Thirty-one point seven percent of the Moraxella catarrhalis isolates were beta-lactamase positive. Beta-lactamase M. catarrhalis were resistant to penicillin and ampicillin while the non-beta-lactamase producers were sensitive to these antimicrobial agents. However, both beta-lactamase producers and non-producers were resistant to Trimethoprim but sensitive to Erythromycin, Tetracycline and Amoxicillin [27]. Osoagbaka conducted a study of the antibiotic sensitivity patterns of nine pathogens isolated from bronchopulmonary infections using the disc diffusion method. Erythromycin, Carbenicillin and Chloramphenicol were in that sequence the drugs most effective against the Gram-positive cocci, followed by Ampicillin to which, however, 56% of the strains of Staphylococcus aureus tested showed resistance. More than 95% of the strains of Haemophilus influenza were very susceptible to Carbenicillin and Chloramphenicol while over 70% were sensitive to Ampicillin, Penicillin G, and Erythromycin. All strains of Pseudomonas aeruginosa tested were sensitive to Carbenicillin and Gentamicin. Klebsiella pneumoniae was moderately sensitive to Tetracycline, Carbenicillin, Streptomycin, Gentamicin and Septrin (Co-trimoxazole). Sixty-seven percent of Escherichia coli were sensitive to Septrin while 50% were susceptible to Chloramphenicol, Erythromycin and Ampicillin. In general there was evidence that Tetracycline, Septrin, Penicillin G, Streptomycin and Orbenin had become less effective against most of the respiratory tract pathogens [28]. 
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